mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.0007 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0009 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0009 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.001 |